(Q37303959)

19 August 2017

1 reference

title

Self-amplification of nigral degeneration in Parkinson's disease: a hypothesis (English)

1 reference

19 August 2017

1 reference

Ilya D Ionov

1

1 reference

19 August 2017

publication date

1 December 2008

1 reference

International Journal of Neuroscience

19 August 2017

published in

1 reference

19 August 2017

volume

118

1 reference

19 August 2017

issue

12

1 reference

19 August 2017

page(s)

1763-1780

1 reference

Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Glutamate Receptors of a Quisqualate-Kainate Subtype are Involved in the Presynaptic Regulation of Dopamine Release in the Cat Caudate Nucleus in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Cytofluorescence localization of adriamycin in the nervous system. I. Distribution of the drug in the central nervous system of normal adult mice after intravenous injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

In vivo noradrenaline release evoked in the anteroventral thalamic nucleus by locus coeruleus activation: an electrochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Substance P excitation of rat locus coeruleus neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Experimental study of serum substantia nigra neuron autoantibody and its effect in Parkinson disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Pathologic correlates of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Decrease in blood histamine in drug-treated parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Immunoreactive substance P and somatostatin in the cerebrospinal fluid of senile parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

The blood-brain barrier in hypoxia: ultrastructural aspects and adenylate cyclase activity of brain capillaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Two components of blood-brain barrier disruption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Circumventricular organs: definition and role in the regulation of endocrine and autonomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Cerebral blood flow and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Evidence for the involvement of histamine in the regulation of blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

ACh, substance P and met-enkephalin in the locus coeruleus: Pharmacological evidence for independent sites of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Glutamate ejection in the locus coeruleus enhances the perforant path-evoked population spike in the dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Brain edema and cerebrovascular permeability during cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Somatostatin induces striatal dopamine release and contralateral turning behaviour in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Antibodies to human caudate nucleus neurons in Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Ventricular fluid neuropeptides in Parkinson's disease. I. Levels and distribution of somatostatin-like immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Cerebral Blood Flow and Dementia in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Catalase and alpha-tocopherol attenuate blood-brain barrier breakdown in pentylenetetrazole-induced epileptic seizures in acute hyperglycaemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Regional Cerebral Blood Flow in Patients With Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disea

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Ultrasound, microbubbles and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Stimulation of dopamine release from cultured rat mesencephalic cells by naturally occurring excitatory amino acids: involvement of both N-methyl-D-aspartate (NMDA) and non-NMDA receptor subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Comparative investigations on the actions of ACTH1-24, somatostatin, neurotensin, substance P and vasopressin on locus coeruleus neuronal activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

The neuropathologic basis of different clinical subgroups of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

The need for neuroprotective therapies in Parkinson's disease: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

COHORT ANALYSIS OF PARKINSON'S SYNDROME: EVIDENCE FOR A SINGLE ETIOLOGY RELATED TO SUBCLINICAL INFECTION ABOUT 1920.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Physiological release of striatal acetylcholine (in vivo): effect of somatostatin on dopaminergic-cholinergic interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Striatal dopamine and glutamate release: effects of intranigral injections of substance P

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

DNA damage and chronic neuronal degenerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Xenon contrast CT-CBF measurements in parkinsonism and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

The role of environmental toxins in the etiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Effects of antioxidants on the blood-brain barrier and postischemic hyperemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Action tremor in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Locus ceruleus activation initiates delayed synaptic potentiation of perforant path input to the dentate gyrus in awake rats: a novel beta-adrenergic- and protein synthesis-dependent mammalian plasticity mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Genetic and environmental factors in the cause of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Role of inflammation in gastrointestinal tract in aetiology and pathogenesis of idiopathic parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

The possible role of iron in the etiopathology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Interaction between free radicals and excitatory amino acids in the blood-brain barrier disruption after iron injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207450802330561

10.1080/00207450802330561

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference